Teva Pharmaceuticals USA, Inc. v. Synthon Pharmaceuticals, Inc.

COMPLAINT against Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Filing Fee $ 400.00, Receipt Number 0208-13206196)Document filed by Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd.. (Attachments: # 1 Exhibit A)(Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

Download

COMPLAINT against Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Filing Fee $ 400.00, Receipt Number 0208-13206196)Document filed by Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd.. (Attachments: # 1 Exhibit A)(Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

2

View

CIVIL COVER SHEET filed. (Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

REQUEST FOR ISSUANCE OF SUMMONS as to Pfizer, Inc., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

REQUEST FOR ISSUANCE OF SUMMONS as to Synthon B.V., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

REQUEST FOR ISSUANCE OF SUMMONS as to Synthon Pharmaceuticals Inc., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

REQUEST FOR ISSUANCE OF SUMMONS as to Synthon S.R.O., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Teva Pharmaceuticals USA, Inc., Other Affiliate Teva Neuroscience, Inc. for Teva Pharmaceuticals Industries Ltd.; Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Neuroscience, Inc., Teva Pharmaceuticals USA, Inc.. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc..(Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Holland, Elizabeth) (Entered: 01/17/2017)

2017-01-17

1

View

AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (rch) (Entered: 01/18/2017)

2017-01-18

1

View

ELECTRONIC SUMMONS ISSUED as to Pfizer, Inc.. (rch) (Entered: 01/18/2017)

2017-01-18

1

View

ELECTRONIC SUMMONS ISSUED as to Synthon B.V.. (rch) (Entered: 01/18/2017)

2017-01-18

1

View

ELECTRONIC SUMMONS ISSUED as to Synthon Pharmaceuticals, Inc.. (rch) (Entered: 01/18/2017)

2017-01-18

1

View

ELECTRONIC SUMMONS ISSUED as to Synthon S.R.O.. (rch) (Entered: 01/18/2017)

2017-01-18

1

View

Case Opening Initial Assignment Notice

2017-01-18

1

No Actions

ORDER: Initial Conference set for 3/8/2017 at 10:20 AM in Courtroom 1106, Thurgood Marshal Courthouse, 40 Foley Square, New York, NY 10007 before Judge Lorna G. Schofield. IT IS ORDERED that the parties shall appear for an initial pretrial conference with the Court at the time and place listed below. All pretrial conferences must be attended by the attorney who will serve as principal counsel. Parties who are not local (within the Metropolitan tri-state area) may request to attend by phone by filing a letter motion via ECF. At theconference, in addition to discussing the matters below, the Court would appreciate counsel's thoughts on how to improve this Order and other matters relating to the judicial management of patent cases. IT IS FURTHER ORDERED that counsel shall confer with each other prior to the conference regarding settlement and each of the other subjects to be considered at a Fed. R. Civ. P. 16 conference. IT IS FURTHER ORDERED that the parties shall file a joint letter on ECF at least seven calendar days prior to the initial pre-trial conference, not to exceed 5 pages. IT IS FURTHER ORDERED that the parties shall file with their joint letter a joint Proposed Civil Case Management Plan and Scheduling Order that incorporates the dates and instructions below and includes dates for the orderly simultaneous progress of any non-patent claims alleged in the Complaint. All dates that can be calculated must appear in the proposed order. Instructions may be incorporated by reference. The parties must propose dates for the various deadlines even if they intend to request a stay of discovery. Counsel who have noticed an appearance as of the issuance of this order are directed (i) to notify all other parties' attorneys in this action by serving upon each of them a copy of this order and the Court's Individual Rules forthwith, and (ii) to file proof of such notice with the Court. If unaware of the identity of counsel for any of the parties, counsel receiving this order must send a copy of this order and Individual Rules to that party personally. DATE AND PLACE OF CONFERENCE: March 8, 2017 at 10:20 a.m., inCourtroom 1106 of the United States District Court for the Southern District of New York, Thurgood Marshall U.S. Courthouse at 40 Foley Square, New York, New York. (Signed by Judge Lorna G. Schofield on 1/23/2017) (anc) (Entered: 01/23/2017)

2017-01-23

1

View

LETTER MOTION for Oral Argument and issuance of briefing schedule for Plaintiffs' motion for preliminary injunction, and rescheduling of Rule 16 Conference addressed to Judge Lorna G. Schofield from Elizabeth J. Holland dated February 1, 2017. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc..(Holland, Elizabeth) (Entered: 02/01/2017)

2017-02-01

1

View

SUMMONS RETURNED EXECUTED. Synthon Pharmaceuticals, Inc. served on 1/17/2017, answer due 2/7/2017. Service was accepted by Kimberly Edgerton, Director. Document filed by Teva Pharmaceuticals USA, Inc.; Teva Neuroscience, Inc.; Teva Pharmaceuticals Industries Ltd.. (Attachments: # 1 Affidavit)(Holland, Elizabeth) (Entered: 02/02/2017)

2017-02-02

1

View

SUMMONS RETURNED EXECUTED. Pfizer, Inc. served on 1/17/2017, answer due 2/7/2017. Service was accepted by Alys M. Kremer, Manager of the Litigation Department. Document filed by Teva Pharmaceuticals USA, Inc.; Teva Neuroscience, Inc.; Teva Pharmaceuticals Industries Ltd.. (Attachments: # 1 Affidavit)(Holland, Elizabeth) (Entered: 02/02/2017)

2017-02-02

1

View

ORDER granting 15 Letter Motion for Oral Argument and issuance of briefing schedule for Plaintiffs' motion for preliminary injunction, and rescheduling of Rule 16 Conference. A telephone conference will be held on February 8, 2017, at 10:10 a.m. At the appointed time, the parties shall jointly call Chambers at (212) 805-0288. By February 7, 2017, at noon, Defendant shall file a letter response regarding Teva's proposed motion and briefing schedule. Plaintiff shall file proof of service of the summons and the complaint. Plaintiff must also provide a copy of this letter to Defendant as soon as possible and no later than the end of today.. (Signed by Judge Lorna G. Schofield on 2/2/2017) (cla) (Entered: 02/02/2017)

2017-02-02

1

View

NOTICE OF APPEARANCE by David M. Hashmall on behalf of Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Hashmall, David) (Entered: 02/03/2017)

2017-02-03

1

View

NOTICE OF APPEARANCE by William G. James, II on behalf of Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (James, William) (Entered: 02/03/2017)

2017-02-03

1

View

NOTICE OF APPEARANCE by Eric Jonathan Seiler on behalf of Pfizer, Inc.. (Seiler, Eric) (Entered: 02/07/2017)

2017-02-07

1

View

NOTICE OF APPEARANCE by John Nicholas Orsini on behalf of Pfizer, Inc.. (Orsini, John) (Entered: 02/07/2017)

2017-02-07

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Pfizer, Inc..(Seiler, Eric) (Entered: 02/07/2017)

2017-02-07

1

View

LETTER addressed to Judge Lorna G. Schofield from Eric Seiler dated February 7, 2017 Document filed by Pfizer, Inc.. (Attachments: # 1 Exhibit 1)(Seiler, Eric) (Entered: 02/07/2017)

2017-02-07

1

View

NOTICE OF APPEARANCE by Daniel Peter Margolis on behalf of Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Margolis, Daniel) (Entered: 02/07/2017)

2017-02-07

1

View

MOTION for Edward Anthony Figg to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13289653. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Pfizer, Inc.. (Attachments: # 1 Affidavit of E. Figg, # 2 Exhibit A - Certificates of Good Standing, # 3 Text of Proposed Order Proposed Order)(Figg, Edward) (Entered: 02/07/2017)

2017-02-07

1

View

MOTION for Sharon Davis to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13289738. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Pfizer, Inc.. (Attachments: # 1 Affidavit of S. Davis, # 2 Exhibit A - Certificate of Good Standing, # 3 Proposed Order)(Davis, Sharon) (Entered: 02/07/2017)

2017-02-07

1

View

MOTION for Seth Cockrum to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13289789. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Pfizer, Inc.. (Attachments: # 1 Affidavit of S. Cockrum, # 2 Exhibit A - Certificates of Good Standing, # 3 Proposed Order)(Cockrum, Seth) (Entered: 02/07/2017)

2017-02-07

1

View

MOTION for Brett Postal to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13289825. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Pfizer, Inc.. (Attachments: # 1 Affidavit of B. Postal, # 2 Exhibit A - Certificates of Good Standing, # 3 Proposed Order)(Postal, Brett) (Entered: 02/07/2017)

2017-02-07

1

View

MOTION for Jennifer Phend Nock to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13291707. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Pfizer, Inc.. (Attachments: # 1 Affidavit of J. Nock, # 2 Exhibit A - Certificates of Good Standing, # 3 Proposed Order)(Nock, Jennifer) (Entered: 02/08/2017)

2017-02-08

1

View

ORDER: That by February 13, 2017, Defendant Pfizer shall file a motion to transfer venue, and the Synthon Defendants shall file a motion to dismiss for lack of personal jurisdiction or, in the alternative, to transfer venue. Defendants shall file a single memorandum of law in support of the motions. By February 24, 2017, Plaintiffs shall file their response to Defendants'motions. By March 1, 2017, Defendants shall file their reply. The parties shall consult and abide by the Court's individual rules regarding page limits, courtesy copies and the like. It is further ORDERED that the foregoing briefing schedule is subject to the parties' agreement regarding the proposed notice period they referenced at today's conference, which agreement shall be filed no later than February 10, 2017. It is further ORDERED that the initial pretrial conference, currently set for March 8, 2017, is adjourned sine die. (Motions due by 2/13/2017. Responses due by 2/24/2017. Replies due by 3/1/2017.) (Signed by Judge Lorna G. Schofield on 2/8/2017) (anc) (Entered: 02/08/2017)

2017-02-08

1

View

Notice Regarding Pro Hac Vice Motion

2017-02-08

1

No Actions

MOTION for Nechama Potasnick to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13309832. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Pfizer, Inc.. (Attachments: # 1 Affidavit of N. Potasnick, # 2 Exhibit A - Certificates of Good Standing, # 3 Proposed Order)(Potasnick, Nechama) (Entered: 02/13/2017)

2017-02-13

1

View

NOTICE OF APPEARANCE by Eric Jonathan Seiler on behalf of Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Seiler, Eric) (Entered: 02/13/2017)

2017-02-13

1

View

NOTICE OF APPEARANCE by John Nicholas Orsini on behalf of Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Orsini, John) (Entered: 02/13/2017)

2017-02-13

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Synthon Pharmaceuticals, Inc..(Orsini, John) (Entered: 02/13/2017)

2017-02-13

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Synthon B.V..(Orsini, John) (Entered: 02/13/2017)

2017-02-13

1

View

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Synthon S.R.O..(Orsini, John) (Entered: 02/13/2017)

2017-02-13

1

View

ORDER: It is hereby ORDERED that the parties' application regarding Individual Rule III.A.3 is GRANTED. The parties do not need to exchange letters in accordance before the Synthon Defendants file their motion to dismiss. It is further ORDERED that the parties' request to file the February 9, 2017, letter under seal is DENIED without prejudice to renewal. There is a presumption of public access to judicial documents. Lugosch v. Pyramid Co. of Onondoga, 435 F.3d 110, 11920 (2d Cir. 2006). When evaluating a request to file under seal, a court balances the weight given to the presumption of access in a particular case with any "competing considerations." Id. (internal quotation marks omitted); see also Nixon v. Warner Commc'ns., Inc., 435 U.S. 589, 599 (1978) ("[T]he decision as to access is one best left to the sound discretion of the trial court, a discretion to be exercised in light of the relevant facts and circumstances of the particular case."). In accordance with Individual Rule I.C.3, any party with an interest in confidential treatment of the February 9, 2017, letter shall submit a letter by February 16, 2017, providing argument and a factual basis, if any, as to why the Court should permit the parties to file the letter under seal. (Signed by Judge Lorna G. Schofield on 2/13/2017) (mro) (Entered: 02/14/2017)

2017-02-13

1

View

Notice Regarding Pro Hac Vice Motion

2017-02-14

1

No Actions

ANSWER to 1 Complaint,., COUNTERCLAIM against Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. Document filed by Pfizer, Inc..(Orsini, John) (Entered: 02/16/2017)

2017-02-16

1

View

ORDER: It is hereby ORDERED that the parties' requests to file on ECF the proposed redacted versions of (1) the February 9 letter, (2) the Memorandum and (3) the Sewalt Declaration are GRANTED. Cf. N.Y. v. Actavis, PLC, No. 14 Civ. 7473, 2014 WL 5353774, at *3 (S.D.N.Y. Oct. 21, 2014) ("Internal documents... that contain non-public strategies... constitute 'confidential commercial information'" that justify confidential treatment, "particularly where the disclosing company is engaged in a highly competitive industry and deliberately has shielded such information from its competitors."). It is further ORDERED that by February 20, 2017, Plaintiff shall file the proposed submissions in redacted form on ECF and file the unredacted versions of the documents under seal. (Signed by Judge Lorna G. Schofield on 2/17/2017) (kgo) Modified on 2/22/2017 (kgo). (Entered: 02/17/2017)

2017-02-17

1

View

TRANSCRIPT of Proceedings re: CONFERNECE held on 2/8/2017 before Judge Lorna G. Schofield. Court Reporter/Transcriber: Steven Griffing, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/10/2017. Redacted Transcript Deadline set for 3/20/2017. Release of Transcript Restriction set for 5/18/2017.(McGuirk, Kelly) (Entered: 02/17/2017)

2017-02-17

1

View

NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 2/8/17 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...(McGuirk, Kelly) (Entered: 02/17/2017)

2017-02-17

1

View

MOTION to Transfer Case . Document filed by Pfizer, Inc..(Orsini, John) (Entered: 02/20/2017)

2017-02-20

1

View

MOTION to Transfer Case . Document filed by Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O..(Orsini, John) (Entered: 02/20/2017)

2017-02-20

1

View

JOINT MEMORANDUM OF LAW in Support re: 43 MOTION to Transfer Case ., 44 MOTION to Transfer Case . [REDACTED]. Document filed by Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Attachments: # 1 Exhibit A)(Orsini, John) (Entered: 02/20/2017)

2017-02-20

1

View

MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION]. Document filed by Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O..(Orsini, John) (Entered: 02/20/2017)

2017-02-20

1

View

DECLARATION of Richard Sewalt [REDACTED] in Support re: 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION].. Document filed by Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Orsini, John) (Entered: 02/20/2017)

2017-02-20

1

View

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated February 9, 2017 [REDACTED] Document filed by Pfizer, Inc..(Orsini, John) (Entered: 02/20/2017)

2017-02-20

1

View

SEALED DOCUMENT placed in vault.(mps) (Entered: 02/21/2017)

2017-02-21

1

View

ORDER granting 29 Motion for Brett Postal to Appear Pro Hac Vice; granting 30 Motion for Jennifer Phend Nock to Appear Pro Hac Vice; granting 32 Motion for Nechama Potasnick to Appear Pro Hac Vice; granting 26 Motion for Edward Anthony Figg to Appear Pro Hac Vice; granting 27 Motion for Sharon Davis to Appear Pro Hac Vice; and granting 28 Motion for Seth Cockrum to Appear Pro Hac Vice. (HEREBY ORDERED by Judge Lorna G. Schofield)(Text Only Order) (Schofield, Lorna) (Entered: 02/21/2017)

2017-02-21

1

View

Sealed Document

2017-02-21

1

No Actions

Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice

2017-02-21

1

No Actions

MOTION for Brian T. Drummond to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13349881. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit of Brian T. Drummond in Support of Motion for Admission Pro Hac Vice, # 2 Exhibit 1- Certificates of Good Standing, # 3 Text of Proposed Order)(Drummond, Brian) (Entered: 02/23/2017)

2017-02-23

1

View

MOTION for Daryl L. Wiesen to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13350238. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit of Daryl L. Wiesen in Support of Motion for Admission Pro Hac Vice, # 2 Exhibit 1-Certificate of Good Standing, # 3 Text of Proposed Order)(Wiesen, Daryl) (Entered: 02/23/2017)

2017-02-23

1

View

MOTION for John T. Bennett to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13350284. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit of John T. Bennett in Support of Motion for Admission Pro Hac Vice, # 2 Exhibit 1- Certificate of Good Standing, # 3 Text of Proposed Order)(Bennett, John) (Entered: 02/23/2017)

2017-02-23

1

View

MOTION for Nicholas K. Mitrokostas to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13350304. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Affidavit of Nicholas K. Mitrokostas in Support of Motion for Admission Pro Hac Vice, # 2 Exhibit 1- Certificates of Good Standing, # 3 Text of Proposed Order)(Mitrokostas, Nicholas) (Entered: 02/23/2017)

2017-02-23

1

View

Notice Regarding Pro Hac Vice Motion

2017-02-24

1

No Actions

ORDER granting 51 Motion for Brian T. Drummond to Appear Pro Hac Vice; granting 52 Motion for Daryl L. Wiesen to Appear Pro Hac Vice; granting 53 Motion for John T. Bennett to Appear Pro Hac Vice; and granting 54 Motion for Nicholas K. Mitrokostas to Appear Pro Hac Vice (HEREBY ORDERED by Judge Lorna G. Schofield)(Text Only Order) (Schofield, Lorna) (Entered: 02/27/2017)

2017-02-27

1

View

Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice

2017-02-27

1

No Actions

ORDER: It is hereby ORDERED that, in light of the foregoing admission that Defendants have "enter[ed] into" a "agreement" that provides Defendant Pfizer with "exclusive rights to commercialize" Synthon's 40mg/ml formulation of glatiramer acetate in the United States, Plaintiffs' application is DENIED. ORDERED that, Plaintiffs shall file, no later than March 6, 2017, any motion to file a version of the Agreement that redacts non-public, commercially sensitive information that is entitled to protection from disclosure under Second Circuit law. Any such motion shall comply with the Court's individual rules concerning applications to redact. In no event will the Court permit the parties to redact Section 13 of Defendants' agreement. Motions due by 3/6/2017. (Signed by Judge Lorna G. Schofield on 3/1/2017) (kgo) (Entered: 03/01/2017)

2017-03-01

1

View

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated March 1, 2017 Document filed by Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O..(Orsini, John) (Entered: 03/01/2017)

2017-03-01

1

View

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated March 7, 2017 Document filed by Pfizer, Inc..(Orsini, John) (Entered: 03/07/2017)

2017-03-07

1

View

ANSWER to 39 Counterclaim. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc..(Holland, Elizabeth) (Entered: 03/09/2017)

2017-03-09

1

View

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated March 10, 2017 Document filed by Pfizer, Inc.. (Attachments: # 1 N.D.W. Va. Opinion and Order)(Orsini, John) (Entered: 03/10/2017)

2017-03-10

1

View

ORDER: ORDERED that the redaction requests are GRANTED. GoSMiLE, Inc. v. Dr. Jonathan Levine, D.M.D. P.C., 769 F. Supp. 2d 630, 649-50 (S.D.N.Y. 2011) (permitting parties to redact highly proprietary material concerning the defendants marketing strategies, product development, costs and budgeting). It is further ORDERED that by March 15, 2017, the parties shall file the redacted versions of the Plaintiffs opposition, Exhibit 4 to the Declaration of Joshua Weinger, and Defendants reply. (Signed by Judge Lorna G. Schofield on 03/13/2017) (ap) (Entered: 03/13/2017)

2017-03-13

1

View

SUMMONS RETURNED EXECUTED. Synthon B.V. served on 2/13/2017, answer due 3/6/2017. Service was accepted by Brett A. Postal, Counsel for the Defendant. Document filed by Teva Neuroscience, Inc.; Teva Pharmaceuticals Industries Ltd.; Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 03/15/2017)

2017-03-15

1

View

SUMMONS RETURNED EXECUTED. Synthon S.R.O. served on 2/13/2017, answer due 3/6/2017. Service was accepted by Brett A. Postal, Counsel for the Defendant. Document filed by Teva Neuroscience, Inc.; Teva Pharmaceuticals Industries Ltd.; Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 03/15/2017)

2017-03-15

1

View

MEMORANDUM OF LAW in Opposition re: 43 MOTION to Transfer Case ., 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION]. . Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 03/15/2017)

2017-03-15

1

View

DECLARATION of Joshua S. Weinger in Opposition re: 43 MOTION to Transfer Case ., 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION].. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1 to Weinger Declaration, # 2 Exhibit 2 to Weinger Declaration, # 3 Exhibit 3 to Weinger Declaration, # 4 Exhibit 4 (REDACTED) to Weinger Declaration, # 5 Exhibit 5 to Weinger Declaration, # 6 Exhibit 6 to Weinger Declaration, # 7 Exhibit 7 to Weinger Declaration, # 8 Exhibit 8 to Weinger Declaration)(Holland, Elizabeth) (Entered: 03/15/2017)

2017-03-15

1

View

DECLARATION of Lori A. Wolfe in Opposition re: 43 MOTION to Transfer Case ., 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION].. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 03/15/2017)

2017-03-15

1

View

REPLY MEMORANDUM OF LAW in Support re: 43 MOTION to Transfer Case ., 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION]. [REDACTED]. Document filed by Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Orsini, John) (Entered: 03/15/2017)

2017-03-15

1

View

DECLARATION of Nechama E. Potasnick in Support re: 43 MOTION to Transfer Case ., 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION].. Document filed by Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Attachments: # 1 Exhibit A (Excerpt of Synthon's Answer and Counterclaim), # 2 Exhibit B (Notice of Motion to Transfer DNJ), # 3 Exhibit C (Motion to Transfer DDE), # 4 Exhibit D (Motion to Transfer DNJ), # 5 Exhibit E (Excerpts of trial transcripts DDE), # 6 Exhibit F (Excerpt from Wynn Declaration DNJ), # 7 Exhibit G (First page of Hassler Declaration DNJ))(Orsini, John) (Entered: 03/15/2017)

2017-03-15

1

View

ORDER. It is hereby ORDERED that Defendants' motion to transfer is GRANTED, and the Synthon Defendants' motion to dismiss for lack of personal jurisdiction is DENIED as moot, and as further specified and set forth in this Order. The Clerk of Court is respectfully directed to transfer the case to the District of Delaware. Granting 43 Motion to Transfer Case; Granting 44 Motion to Transfer Case; Denying as moot 46 Motion to Dismiss. (Signed by Judge Lorna G. Schofield on 3/31/2017) (rjm) (Entered: 03/31/2017)

2017-03-31

1

View

Case Transferred Out - District Transfer

2017-04-07

1

No Actions

Received Acknowledgment (Electronic Case Transfer)

2017-04-10

1

No Actions

Sealed Document Attorney Notice to Retrieve

2024-03-12

1

View

Sealed Document Disposed

2024-04-15

1

No Actions

Overview

Parties

Defendant

Synthon S.R.O. Follow

Represented By

Synthon Pharmaceuticals, Inc. Follow

Represented By

Teva Pharmaceuticals Industries Ltd. Follow

Represented By

Teva Pharmaceuticals USA, Inc. Follow

Represented By

Pfizer, Inc. Follow

Represented By

Plaintiff

Teva Neuroscience, Inc. Follow

Represented By

Counter Claimant

Synthon B.V. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

CIVIL COVER SHEET filed. (Holland, Elizabeth) (Entered: 01/17/2017)

REQUEST FOR ISSUANCE OF SUMMONS as to Pfizer, Inc., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

REQUEST FOR ISSUANCE OF SUMMONS as to Synthon B.V., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

REQUEST FOR ISSUANCE OF SUMMONS as to Synthon Pharmaceuticals Inc., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

REQUEST FOR ISSUANCE OF SUMMONS as to Synthon S.R.O., re: 1 Complaint,. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Holland, Elizabeth) (Entered: 01/17/2017)

AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Holland, Elizabeth) (Entered: 01/17/2017)

ELECTRONIC SUMMONS ISSUED as to Pfizer, Inc.. (rch) (Entered: 01/18/2017)

ELECTRONIC SUMMONS ISSUED as to Synthon B.V.. (rch) (Entered: 01/18/2017)

ELECTRONIC SUMMONS ISSUED as to Synthon Pharmaceuticals, Inc.. (rch) (Entered: 01/18/2017)

ELECTRONIC SUMMONS ISSUED as to Synthon S.R.O.. (rch) (Entered: 01/18/2017)

Case Opening Initial Assignment Notice

NOTICE OF APPEARANCE by David M. Hashmall on behalf of Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Hashmall, David) (Entered: 02/03/2017)

NOTICE OF APPEARANCE by William G. James, II on behalf of Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (James, William) (Entered: 02/03/2017)

NOTICE OF APPEARANCE by Eric Jonathan Seiler on behalf of Pfizer, Inc.. (Seiler, Eric) (Entered: 02/07/2017)

NOTICE OF APPEARANCE by John Nicholas Orsini on behalf of Pfizer, Inc.. (Orsini, John) (Entered: 02/07/2017)

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Pfizer, Inc..(Seiler, Eric) (Entered: 02/07/2017)

LETTER addressed to Judge Lorna G. Schofield from Eric Seiler dated February 7, 2017 Document filed by Pfizer, Inc.. (Attachments: # 1 Exhibit 1)(Seiler, Eric) (Entered: 02/07/2017)

NOTICE OF APPEARANCE by Daniel Peter Margolis on behalf of Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Margolis, Daniel) (Entered: 02/07/2017)

Notice Regarding Pro Hac Vice Motion

NOTICE OF APPEARANCE by Eric Jonathan Seiler on behalf of Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Seiler, Eric) (Entered: 02/13/2017)

NOTICE OF APPEARANCE by John Nicholas Orsini on behalf of Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Orsini, John) (Entered: 02/13/2017)

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Synthon Pharmaceuticals, Inc..(Orsini, John) (Entered: 02/13/2017)

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Synthon B.V..(Orsini, John) (Entered: 02/13/2017)

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Synthon S.R.O..(Orsini, John) (Entered: 02/13/2017)

Notice Regarding Pro Hac Vice Motion

ANSWER to 1 Complaint,., COUNTERCLAIM against Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. Document filed by Pfizer, Inc..(Orsini, John) (Entered: 02/16/2017)

MOTION to Transfer Case . Document filed by Pfizer, Inc..(Orsini, John) (Entered: 02/20/2017)

MOTION to Transfer Case . Document filed by Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O..(Orsini, John) (Entered: 02/20/2017)

JOINT MEMORANDUM OF LAW in Support re: 43 MOTION to Transfer Case ., 44 MOTION to Transfer Case . [REDACTED]. Document filed by Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Attachments: # 1 Exhibit A)(Orsini, John) (Entered: 02/20/2017)

MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION]. Document filed by Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O..(Orsini, John) (Entered: 02/20/2017)

DECLARATION of Richard Sewalt [REDACTED] in Support re: 46 MOTION to Dismiss Notice of Synthon Defendants' Motion to Dismiss or Alternatively, to Transfer [Correcting 44 MOTION].. Document filed by Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O.. (Orsini, John) (Entered: 02/20/2017)

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated February 9, 2017 [REDACTED] Document filed by Pfizer, Inc..(Orsini, John) (Entered: 02/20/2017)

SEALED DOCUMENT placed in vault.(mps) (Entered: 02/21/2017)

Sealed Document

Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice

Notice Regarding Pro Hac Vice Motion

Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice AND Order on Motion to Appear Pro Hac Vice

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated March 1, 2017 Document filed by Pfizer, Inc., Synthon B.V., Synthon Pharmaceuticals, Inc., Synthon S.R.O..(Orsini, John) (Entered: 03/01/2017)

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated March 7, 2017 Document filed by Pfizer, Inc..(Orsini, John) (Entered: 03/07/2017)

ANSWER to 39 Counterclaim. Document filed by Teva Neuroscience, Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc..(Holland, Elizabeth) (Entered: 03/09/2017)

LETTER addressed to Judge Lorna G. Schofield from John N. Orsini dated March 10, 2017 Document filed by Pfizer, Inc.. (Attachments: # 1 N.D.W. Va. Opinion and Order)(Orsini, John) (Entered: 03/10/2017)

Case Transferred Out - District Transfer

Received Acknowledgment (Electronic Case Transfer)

Sealed Document Attorney Notice to Retrieve

Sealed Document Disposed

Track Case Updates

Synthon S.R.O.

Synthon Pharmaceuticals, Inc.

Teva Pharmaceuticals Industries Ltd.

Teva Pharmaceuticals USA, Inc.

Pfizer, Inc.

Teva Neuroscience, Inc.

Synthon B.V.